Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Pacific Biosciences Of California (PACB) Deferred Taxes (2021 - 2025)

Pacific Biosciences Of California has reported Deferred Taxes over the past 4 years, most recently at -$546000.0 for Q1 2025.

For Q1 2025, Deferred Taxes changed N/A year-over-year to -$546000.0; the TTM value through Dec 2025 reached -$546000.0, down 166.34%, while the annual FY2025 figure was -$546000.0, 166.34% down from the prior year.
Deferred Taxes for Q1 2025 was -$546000.0 at Pacific Biosciences Of California, down from -$205000.0 in the prior quarter.
Over five years, Deferred Taxes peaked at $1.2 million in Q4 2021 and troughed at -$718000.0 in Q4 2023.
A 4-year average of -$73500.0 and a median of -$375500.0 in 2024 define the central range for Deferred Taxes.
On a YoY basis, Deferred Taxes climbed as much as 71.45% in 2024 and fell as far as 71.45% in 2024.
Year by year, Deferred Taxes stood at $1.2 million in 2021, then crashed by 161.11% to -$718000.0 in 2023, then skyrocketed by 71.45% to -$205000.0 in 2024, then crashed by 166.34% to -$546000.0 in 2025.
Business Quant data shows Deferred Taxes for PACB at -$546000.0 in Q1 2025, -$205000.0 in Q4 2024, and -$718000.0 in Q4 2023.